---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-012602"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2023-04-17T23:59:59+00:00"
generated_at: "2026-06-17T01:36:29.439630+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Biofrontera settles litigation with Biofrontera AG, expands board, amends rights plan

## Summary
- Settlement resolves Delaware Chancery lawsuit and challenges to Biofrontera AG's January 2023 shareholder meeting.
- Board expands from 5 to 6; Biofrontera AG appoints one Class I director; will add seventh director for 2023 annual meeting.
- Rights Agreement amended: Biofrontera AG's beneficial ownership threshold raised from 20% to 29.96%.
- Related Party Transactions Committee established to approve all deals between Biofrontera Inc. and Biofrontera AG.
- Standstill: Biofrontera AG cannot buy additional shares without committee OK; must vote with Board through 2025.

## SEC filing metadata
- accession: 0001493152-23-012602
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2023-04-17T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315223012602/0001493152-23-012602-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315223012602/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-012602
- JSON: https://secwatch.observer/filing/0001493152-23-012602.json
- Plain text: https://secwatch.observer/filing/0001493152-23-012602.txt

## Key facts
- Material Agreements
  Biofrontera Inc. entered into Settlement Agreement with Biofrontera AG valued at settlement of disputes related to stockholder meetings and director nominations (effective 2023-04-11).
  - Action: entry
  - Agreement: settlement
  - Counterparty: Biofrontera AG
  - Value: settlement of disputes related to stockholder meetings and director nominations
  - Effective: 2023-04-11
  source text: On April 11, 2023, Biofrontera Inc., a Delaware corporation (the “Company”), and each member of its Board of Directors, in their individual capacities, entered into a settlement agreement (the “Settlement Agreement”) with Biofrontera AG, a significant stockholder of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315223012602/0001493152-23-012602-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.